3 results
To assess the Pharmacokinetic and Pharmacodynamic properties of three dosages of Coagulation Factor VIIa (Recombinant) in congenital hemophilia A or B patientsTo assess the safety of three dosages of Coagulation factor VIIa (Recombinant) in…
The primary objective of this study is to assess the feasibility and safety of the Endologix Fenestrated Stent Graft System for the endovascular repair of juxtarenal or pararenal (JAA/PAA) aortic aneurysms in suitable patients. The primary purpose…
We will assess the safety of adalimumab-800CW through the evaluation of both vital signs after tracer administration and possible (severe) adverse events (SAE/AE*s). Importantly, we will determine the feasibility of molecular fluorescence imaging…